MRIA-9

N/A

Report date: 2023/03/13 11:26:20

NME

Base Information

Drug NameMRIA-9

Drug Alias NameMRIA-9

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerine/threonine-protein kinase SIK2 inhibitorsSerine/threonine-protein kinase PAK 2 inhibitorsSerine/threonine-protein kinase PAK 3 inhibitors

TargetsSerine/threonine-protein kinase SIK2Serine/threonine-protein kinase PAK 2Serine/threonine-protein kinase PAK 3

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGoethe University Frankfurt

China Registration ClassN/A

Develop Information

Active CompaniesGoethe University Frankfurt

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A